Related Experiment Videos
Sunflower-Derived Pectin Oligogalacturonides Promote Defecation in Mice
Hongming Gu1, Xian Qu1, Xiaotong Sheng1
1Engineering Research Center of Glycoconjugates, Ministry of Education, Jilin Provincial Key Laboratory of Chemistry and Biology of Changbai Mountain Natural Drugs, School of Life Sciences, Northeast Normal University, Changchun 130024, China.
Foods (Basel, Switzerland)
|August 13, 2026
Summary
Sunflower pectin fragments, not native pectin, promote defecation. Enzymatically derived oligogalacturonides show enhanced activity as molecular weight decreases, offering potential as functional food ingredients.
Area of Science:
- Food Science
- Biochemistry
- Gastroenterology
Background:
- Sunflower pectin is a common food additive with known gelling and stabilizing properties.
- The bioactive potential of sunflower pectin, particularly its effect on gut function, is not well understood.
Purpose of the Study:
- To investigate the effect of sunflower pectin on defecation.
- To explore the potential of biotransformed pectin fragments in promoting defecation.
Main Methods:
- A diphenoxylate-induced constipation mouse model was used to assess defecation.
- Sunflower pectin was enzymatically hydrolyzed to produce fragments of varying molecular weights and esterification states.
- The defecation-promoting and prebiotic effects of pectin fragments were evaluated.
Main Results:
- Native sunflower pectins showed no significant effect on defecation.
- Enzymatically derived pectin fragments, particularly oligogalacturonides, exhibited significant defecation-promoting effects.
- Defecation-promoting activity increased as molecular weight decreased, with E3 (DP3-DP4) being the most effective fraction.
- E3 also demonstrated prebiotic effects in the gut.
Conclusions:
- Biotransformation can convert ineffective native sunflower pectin into bioactive oligogalacturonides with defecation-promoting properties.
- A lower molecular weight of pectin fragments correlates with increased defecation-promoting activity.
- These findings suggest potential applications for pectin-derived oligogalacturonides as functional food ingredients for gut health.
Related Concept Videos
01:20Drugs Affecting GI Tract Motility: Other Laxatives
Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
01:21Drugs for Treatment of Constipation-Predominant IBS
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
01:22Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This makes...
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This makes...
01:17Drugs for Treatment of Diarrhea-Predominant IBS
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...